ScholarIQanswers from OpenAlex & ORCID
David Avigan
ResearcherPublications, citations & collaboration network
David Avigan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David Avigan have?
ScholarIQindexed works
David Avigan has 563 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David Avigan have?
ScholarIQcitation count
David Avigan has 18,721 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David Avigan?
ScholarIQh-index
David Avigan has an h-index of 60 in OpenAlex.
What is the i10-index of David Avigan?
ScholarIQi10-index
David Avigan has an i10-index of 168 in OpenAlex.
What is the ORCID of David Avigan?
ScholarIQorcid
The ORCID for David Avigan is on the source record.
What is the OpenAlex record for David Avigan?
ScholarIQopenalex
The OpenAlex for David Avigan is on the source record.
What are the most-cited papers on David Avigan?
ScholarIQmost cited works
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D. Cohen, A. Keith Stewart, Parameswaran Hari, Myo Htut, Alexander M. Lesokhin, Abhinav Deol, Nikhil C. Munshi, Elizabeth O’Donnell, David Avigan, Indrajeet Singh, Enrique Zudaire, Tzu‐Min Yeh, Alicia J. Allred, Yunsi Olyslager, Arnob Banerjee, Carolyn C. Jackson, Jenna D Goldberg, Jordan M. Schecter, William Deraedt, Sen Hong Zhuang, Jeffrey R. Infante, Dong Geng, Xiaoling Wu, Marlene J. Carrasco-Alfonso, Muhammad Akram, Farah Hossain, Syed Rizvi, Frank Fan, Yi Lin, Thomas G. Martin, Sundar Jagannath
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Paul G. Richardson, Edie Weller, Sagar Lonial, Andrzej Jakubowiak, Sundar Jagannath, Noopur Raje, David Avigan, Wanling Xie, Irene M. Ghobrial, Robert Schlossman, Amitabha Mazumder, Nikhil C. Munshi, David H. Vesole, Robin Joyce, Jonathan L. Kaufman, Deborah Doss, Diane Warren, Laura Lunde, Sarah Kaster, Carol Delaney, Teru Hideshima, Constantine S. Mitsiades, Robert Knight, Dixie‐Lee Esseltine, Kenneth C. Anderson
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Philippe Armand, Arnon Nagler, Edie Weller, Steven M. Devine, David Avigan, Yi‐Bin Chen, Mark Kaminski, H. Kent Holland, Jane N. Winter, James R. Mason, Joseph W. Fay, David A. Rizzieri, Chitra Hosing, Edward D. Ball, Joseph P. Uberti, Hillard M. Lazarus, Markus Y. Mapara, Stephanie A. Gregory, John M. Timmerman, David Andorsky, Reuven Or, Edmund K. Waller, Rinat Rotem‐Yehudar, Leo I. Gordon